Darren Flynn1, Richard Francis2, Kristoffer Halvorsrud1, Eduardo Gonzalo-Almorox3, Dawn Craig1, Shannon Robalino1, Peter McMeekin4, Adela Cora2, Joyce Balami5, Gary A Ford2,6, Phil White2. 1. Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, UK. 2. Institute of Neuroscience (Stroke Research Group), Newcastle University, Newcastle Upon Tyne, UK. 3. Newcastle University Business School, Newcastle University, Newcastle Upon Tyne, UK. 4. School of Health, Community and Education Studies, Northumbria University, UK. 5. Centre for Evidence Based Medicine, University of Oxford, Oxford, UK. 6. Oxford University Hospitals NHS Trust and Oxford University, UK.
Abstract
PURPOSE: Intra-arterial mechanical thrombectomy combined with appropriate patient selection (image-based selection of acute ischaemic stroke patients with large artery occlusion) yields improved clinical outcomes. We conducted a systematic review and meta-analysis, with trial sequential analysis to understand the benefits, risks and impact of new trials reporting in 2016 on the magnitude/certainty of the estimates for clinical effectiveness and safety of mechanical thrombectomy. METHOD: Random effects' models were conducted of randomised clinical trials comparing mechanical thrombectomy (stent retriever or aspiration devices) with/without adjuvant intravenous thrombolysis with intravenous thrombolysis and other forms of best medical/supportive care in the treatment of acute ischaemic stroke. Study inclusion and risk of bias were assessed independently by two reviewers. Functional independence (modified Rankin Scale 0-2) and mortality at 90 days, including symptomatic intracranial haemorrhage rate were extracted. Trial sequential analysis established the strength of the evidence derived from the meta-analyses. FINDINGS: Eight trials of mechanical thrombectomy with a total sample size of 1841 (916 patients treated with mechanical thrombectomy and 925 treated without mechanical thrombectomy) fulfilled review inclusion criteria. The three most recent trials more precisely defined the effectiveness of mechanical thrombectomy (modified Rankin Scale 0 to 2; OR = 2.07, 95% CI = 1.70 to 2.51 based on data from eight trials versus OR = 2.39, 95% CI = 1.88 to 3.04 based on data from five trials). Meta-analyses showed no effect on mortality (OR = 0.81, 95% CI = 0.61 to 1.07) or symptomatic intracranial haemorrhage (OR = 1.22, 95% CI = 0.80 to 1.85) as found in analysis of first five trials. Trial sequential analysis indicated that the information size requirement was fulfilled to conclude the evidence for mechanical thrombectomy is robust. DISCUSSION: The impact of three recent trials on effectiveness and safety of mechanical thrombectomy was a more precise pooled effect size for functional independence. Trial sequential analysis demonstrated sufficient evidence for effectiveness and safety of mechanical thrombectomy. CONCLUSION: No further trials of mechanical thrombectomy versus no mechanical thrombectomy are indicated to establish clinical effectiveness. Uncertainty remains as to whether mechanical thrombectomy reduces mortality or increases risk of symptomatic intracranial haemorrhage.
PURPOSE: Intra-arterial mechanical thrombectomy combined with appropriate patient selection (image-based selection of acute ischaemic stroke patients with large artery occlusion) yields improved clinical outcomes. We conducted a systematic review and meta-analysis, with trial sequential analysis to understand the benefits, risks and impact of new trials reporting in 2016 on the magnitude/certainty of the estimates for clinical effectiveness and safety of mechanical thrombectomy. METHOD: Random effects' models were conducted of randomised clinical trials comparing mechanical thrombectomy (stent retriever or aspiration devices) with/without adjuvant intravenous thrombolysis with intravenous thrombolysis and other forms of best medical/supportive care in the treatment of acute ischaemic stroke. Study inclusion and risk of bias were assessed independently by two reviewers. Functional independence (modified Rankin Scale 0-2) and mortality at 90 days, including symptomatic intracranial haemorrhage rate were extracted. Trial sequential analysis established the strength of the evidence derived from the meta-analyses. FINDINGS: Eight trials of mechanical thrombectomy with a total sample size of 1841 (916 patients treated with mechanical thrombectomy and 925 treated without mechanical thrombectomy) fulfilled review inclusion criteria. The three most recent trials more precisely defined the effectiveness of mechanical thrombectomy (modified Rankin Scale 0 to 2; OR = 2.07, 95% CI = 1.70 to 2.51 based on data from eight trials versus OR = 2.39, 95% CI = 1.88 to 3.04 based on data from five trials). Meta-analyses showed no effect on mortality (OR = 0.81, 95% CI = 0.61 to 1.07) or symptomatic intracranial haemorrhage (OR = 1.22, 95% CI = 0.80 to 1.85) as found in analysis of first five trials. Trial sequential analysis indicated that the information size requirement was fulfilled to conclude the evidence for mechanical thrombectomy is robust. DISCUSSION: The impact of three recent trials on effectiveness and safety of mechanical thrombectomy was a more precise pooled effect size for functional independence. Trial sequential analysis demonstrated sufficient evidence for effectiveness and safety of mechanical thrombectomy. CONCLUSION: No further trials of mechanical thrombectomy versus no mechanical thrombectomy are indicated to establish clinical effectiveness. Uncertainty remains as to whether mechanical thrombectomy reduces mortality or increases risk of symptomatic intracranial haemorrhage.
Authors: Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes Journal: Lancet Date: 2010-05-15 Impact factor: 79.321
Authors: Ioannis Christou; Robert A Felberg; Andrew M Demchuk; W Scott Burgin; Marc Malkoff; James C Grotta; Andrei V Alexandrov Journal: J Neuroimaging Date: 2002-04 Impact factor: 2.486
Authors: Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni Journal: N Engl J Med Date: 2008-09-25 Impact factor: 91.245
Authors: Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks Journal: Stroke Date: 2003-07-17 Impact factor: 7.914
Authors: Nils Wahlgren; Niaz Ahmed; Niclas Eriksson; Franz Aichner; Erich Bluhmki; Antoni Dávalos; Terttu Erilä; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Martin Köhrmann; Vincent Larrue; Kennedy R Lees; Thomas Machnig; Risto O Roine; Danilo Toni; Geert Vanhooren Journal: Stroke Date: 2008-10-16 Impact factor: 7.914
Authors: Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen Journal: Lancet Date: 2012-05-23 Impact factor: 79.321
Authors: Joyce S Balami; Diamuid Coughlan; Phil M White; Peter McMeekin; Darren Flynn; Christine Roffe; Indira Natarajan; Jayan Chembala; Sanjeev Nayak; Ivan Wiggam; Peter Flynn; Robert Simister; Yazen Sammaraiee; Don Sims; Kurdow Nader; Anand Dixit; Dawn Craig; Hannah Lumley; Stephen Rice; David Burgess; Lisa Foddy; Emer Hopkins; Beverley Hudson; Rachael Jones; Martin A James; Alastair M Buchan; Gary A Ford; Alastair M Gray Journal: Clin Med (Lond) Date: 2020-05 Impact factor: 2.659
Authors: Michael Allen; Kerry Pearn; Martin James; Gary A Ford; Phil White; Anthony G Rudd; Peter McMeekin; Ken Stein Journal: Eur Stroke J Date: 2018-07-19
Authors: Peter McMeekin; Darren Flynn; Mike Allen; Diarmuid Coughlan; Gary A Ford; Hannah Lumley; Joyce S Balami; Martin A James; Ken Stein; David Burgess; Phil White Journal: BMC Health Serv Res Date: 2019-11-08 Impact factor: 2.655
Authors: Michael Allen; Kerry Pearn; Gary A Ford; Phil White; Anthony G Rudd; Peter McMeekin; Ken Stein; Martin James Journal: Eur Stroke J Date: 2021-12-23
Authors: Yasemin Tanyildizi; Emily Payne; Tiemo Gerber; Larissa Seidman; Axel Heimann; Oliver Kempski; Doris Leithner; Andreas Garcia-Bardon; Roman Kloeckner; Felix Hahn; Naureen Keric; Julia Masomi-Bornwasser; Marc A Brockmann; Stefanie Kirschner Journal: Sci Rep Date: 2020-01-20 Impact factor: 4.379